FRANKLIN, Tenn., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report third quarter 2024 financial results after market close on Wednesday, November 6, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on November 6, 2024, to discuss Clover Health’s third quarter 2024 business and financial results. Third Quarter 2024 Conference Call and Webcast Details: What: Clover Health’s Third Quarter 20 ...

Group 1 - The article highlights twelve actionable investment ideas on tickers with less coverage, referred to as "The Undercovered Dozen" [1] - Inclusion criteria for "undercovered" tickers include a market cap greater than $100 million, more than 800 symbol page views in the last 90 days, and fewer than two articles published in the past 30 days [1] - The ideas presented can range from large caps that are considered "boring" to promising small caps that are on the rise [1]

Have you been paying attention to shares of Clover Health Investments, Corp. (CLOV) ? Shares have been on the move with the stock up 50.4% over the past month. The stock hit a new 52-week high of $4.03 in the previous session. Clover Health Investments, Corp. has gained 320.1% since the start of the year compared to the 7.2% move for the Zacks Medical sector and the -9% return for the Zacks Medical Info Systems industry. What's Driving the Outperformance? The stock has an impressive record of positive earni ...

FRANKLIN, Tenn., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover Health" or "Clover"), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced the appointment of Joseph Brand as Chief Operating Officer (COO) for its Medicare Advantage (MA) plan. Mr. Brand will oversee core MA operations and drive performance improvements, with a focus on improving healthcare delivery in New Jersey by lever ...

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks and waiting long for them to recover. They believe instead that one could make far more money in lesser time by "buying high and selling higher." Who doesn't like betting on fast-moving trending stocks? But determining the right entry point isn't easy. Often, these stocks lose momentum once their valuation moves ...

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks and waiting long for them to recover. They believe instead that one could make far more money in lesser time by "buying high and selling higher." Who doesn't like betting on fast-moving trending stocks? But determining the right entry point isn't easy. Often, these stocks lose momentum once their valuation moves ...

FRANKLIN, Tenn., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, at 4:30 p.m. Eastern Time. A live webcast and replay of the presentation will be accessible fr ...

Clover Health (NASDAQ:CLOV) co-founder and Executive Chairman Vivek Garipalli bought 531,700 shares of his troubled health insurance company this month. The executive now owns over 1.4 million shares. Clover Health has 407 million shares outstanding. Warrants could boost that to 497 million shares. Clover came public through a special purpose acquisition company (SPAC) run by Chamath Palihapitiya in 2021. CLOV stock is up more than 10% as of this writing to around $2.2o per share. Its market capitalization ...

Have you been paying attention to shares of Clover Health Investments, Corp. (CLOV) ? Shares have been on the move with the stock up 15.6% over the past month. The stock hit a new 52-week high of $2.03 in the previous session. Clover Health Investments, Corp. has gained 110.1% since the start of the year compared to the 8.2% move for the Zacks Medical sector and the -12% return for the Zacks Medical Info Systems industry. What's Driving the Outperformance? The stock has a great record of positive earnings s ...

Group 1 - Momentum investing focuses on "buying high and selling higher" rather than traditional strategies of "buying low and selling high" [1] - Fast-moving trending stocks can be risky if their valuations exceed future growth potential, leading to potential losses for investors [2] - Investing in bargain stocks with recent price momentum can be a safer strategy, utilizing tools like the Zacks Momentum Style Score to identify opportunities [3] Group 2 - Clover Health Investments, Corp. (CLOV) has shown significant price momentum, with a four-week price change of 24.3% and a 75.9% increase over the past 12 weeks [4][5] - CLOV has a high beta of 2.1, indicating it moves 110% higher than the market, suggesting strong momentum [5] - CLOV has a Momentum Score of A, indicating a favorable time to invest based on its price performance [6] Group 3 - An upward trend in earnings estimate revisions has contributed to CLOV's Zacks Rank 2 (Buy), which is associated with strong momentum effects [7] - CLOV is trading at a Price-to-Sales ratio of 0.49, indicating it is attractively priced at 49 cents for each dollar of sales [7] - CLOV has potential for further growth, supported by its momentum characteristics and reasonable valuation [8] Group 4 - There are additional stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, providing further investment opportunities [8] - Zacks offers over 45 Premium Screens tailored to different investing styles, aiding in stock selection [9]